Literature DB >> 3779612

Cell mediated and humoral immune responses in oral submucous fibrosis.

R Rajendran, C K Sugathan, P Remani, R Ankathil, T Vijayakumar.   

Abstract

Cell-mediated and humoral immune responses were assessed in 50 patients with oral submucous fibrosis (OSMF) and the results were compared with those of 50 patients with oral-leukoplakia, 50 oral cancer patients, and 50 normal healthy adult controls. The number of high-affinity rosette-forming cells (HARFC) was found to be significantly decreased in OSMF and oral cancer, whereas the number of total rosette-forming cells (TRFC) remained unaltered. Levels of serum IgA, IgD, and IgE were found to be elevated both in OSMF and oral cancer. Immunologic derangements were found to be more pronounced in oral cancer than in OSMF. The enumeration of HARFC along with the estimation of serum levels of IgA, IgD, and IgE indicates that OSMF can be an intermediary stage in the malignant transformation of a normal cell, and that these parameters may serve as markers for the early detection of oral cancer.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3779612     DOI: 10.1002/1097-0142(19861215)58:12<2628::aid-cncr2820581214>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

Review 1.  Oral submucosal fibrosis--a preventable disease.

Authors:  V Jayanthi; C S Probert; K S Sher; J F Mayberry
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

2.  Alteration of Serum Lipid in Oral Sub Mucous Fibrosis in Central India.

Authors:  J K Yashveer; Devendra Pankaj
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-06-28

Review 3.  Oral submucous fibrosis: etiology, pathogenesis, and future research.

Authors:  R Rajendran
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

4.  Evaluation of serum immunoglobulin (IgG, IgM, IgA) in potentially malignant disorders of oral cavity - A case control study.

Authors:  Vivek M Tarsariya; Dhaval N Mehta; Nilesh Raval; Hiren H Patadiya; Kanan Vachhrajani; Albert Ashem
Journal:  J Oral Biol Craniofac Res       Date:  2020-09-08

5.  Circulating Immune complexes (CIC) as marker for disease progress in oral cancer.

Authors:  Cynthia Jane; A V Nerurkar; F R Karjodkar
Journal:  Indian J Clin Biochem       Date:  2007-09

6.  α4β1 integrin-dependent cell sorting dictates T-cell recruitment in oral submucous fibrosis.

Authors:  R Rajendran; K Deepthi; Nasser Nooh; Sukumaran Anil
Journal:  J Oral Maxillofac Pathol       Date:  2011-09

7.  Estimation of serum and salivary immunoglobulin G and immunoglobulin A in oral pre-cancer: A study in oral submucous fibrosis and oral lichen planus.

Authors:  V C Divya; S Sathasivasubramanian
Journal:  J Nat Sci Biol Med       Date:  2014-01

8.  PTMA, a new identified autoantigen for oral submucous fibrosis, regulates oral submucous fibroblast proliferation and extracellular matrix.

Authors:  Jie Wang; Jialing You; Lekai Wang; Huimin Wang; Tian Tian; Wenjin Wang; Lina Jia; Canhua Jiang
Journal:  Oncotarget       Date:  2017-08-24

9.  Serum Immunoglobulins as Diagnostic Markers in Smokeless Tobacco Users for Prevention of Oral Potentially Malignant Disorders.

Authors:  Anjani Kumar Shukla; Tanya Khaitan; Prashant Gupta; Shantala Naik
Journal:  Asian Pac J Cancer Prev       Date:  2020-07-01

10.  Estimation of major immunoglobulins in smokers and gutkha chewers.

Authors:  Ketankumar Jayantilal Prajapati; Jyoti G Chawda
Journal:  J Oral Maxillofac Pathol       Date:  2016 May-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.